Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Gallstones in Post-bariatric Surgery Patients
NCT06287931Recruiting
- Sponsor
- Shandong Linglong Yingcheng Hospital
- Start
- Jan 2024
- Primary completion
- Jun 2025
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised trial of Bifidobacterium tetravaccine in cholelithiasis (3 arms), sponsored by Shandong Linglong Yingcheng Hospital. Primary endpoint: The incidence of gallstones in bariatric surgery patients at 1 year. Started Jan 2024; status: recruiting.
02
Drugs
Bifidobacterium tetravaccine
03
Conditions
cholelithiasis
Beyond the preview
Go deeper on NCT06287931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06287931.